Jupiter Staked SOL vs Injective Staking
Side-by-side comparison of JUPSOL and INJ staking yields, risk, and key metrics. Updated every 4 hours.
Detailed comparison
Jupiter Staked SOL vs Injective: which should you stake?
Injective currently offers the higher APY at 6.39% compared to Jupiter Staked SOL's 6.30%. That's a 0.09 percentage point difference in annual yield.
In terms of market cap, Jupiter Staked SOL is the larger asset at $421.76M, which generally indicates more liquidity and lower volatility risk.
Both assets can be staked through various platforms and protocols. Consider diversifying across both rather than choosing one exclusively — this spreads your risk across different networks and ecosystems.
Jupiter Staked SOL vs Injective — common questions
Is Jupiter Staked SOL or Injective better for staking?
Injective currently offers a higher staking APY at 6.39% compared to Jupiter Staked SOL's 6.30%. However, the best choice depends on your risk tolerance, investment horizon, and portfolio strategy.
What is the APY difference between Jupiter Staked SOL and Injective?
Jupiter Staked SOL offers 6.30% APY while Injective offers 6.39% APY — a difference of 0.09 percentage points.
Which is safer to stake: JUPSOL or INJ?
Jupiter Staked SOL has a medium risk rating while Injective has a medium risk rating. Lower risk typically means a more established network with stronger validator infrastructure.
Can I stake both JUPSOL and INJ?
Yes, diversifying across multiple staking assets is a common strategy. Staking both Jupiter Staked SOL and Injective spreads your risk across different networks and protocols.